Last reviewed · How we verify

IPACK and multi-modal analgesic regimen

University Health Network, Toronto · FDA-approved active Small molecule

IPACK (Interscalene block, Pecs block, Axillary block, and Knee block) combined with multi-modal analgesia delivers regional anesthesia and systemic pain relief to reduce postoperative pain and opioid consumption.

IPACK (Interscalene block, Pecs block, Axillary block, and Knee block) combined with multi-modal analgesia delivers regional anesthesia and systemic pain relief to reduce postoperative pain and opioid consumption. Used for Postoperative pain management following shoulder surgery, Postoperative pain management following upper extremity surgery.

At a glance

Generic nameIPACK and multi-modal analgesic regimen
Also known asInfilteration between popliteal artery and posterior capsule of the knee
SponsorUniversity Health Network, Toronto
ModalitySmall molecule
Therapeutic areaPain Management / Anesthesia
PhaseFDA-approved

Mechanism of action

IPACK is a regional anesthesia technique that blocks multiple nerve pathways (interscalene, pectoral, axillary, and knee blocks) to provide localized pain control in the shoulder and upper extremity. When combined with a multi-modal analgesic regimen (typically including NSAIDs, acetaminophen, and other non-opioid agents), it provides comprehensive perioperative pain management that reduces reliance on opioid medications and improves recovery outcomes.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: